MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: TRxCARE
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

/RC/ TRxCARE Introduces New Innovative Treatment and Adherence Support Service - New innovative treatment and adherence support service for patients taking one of gilead sciences hiv medications - TRxCARE.com
/RC/ TRxCARE Introduces New Innovative Treatment and Adherence Support Service

 

NewswireToday - /newswire/ - London, Middlesex, United Kingdom, 2012/11/30 - New innovative treatment and adherence support service for patients taking one of gilead sciences hiv medications - TRxCARE.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

TRxCARE (trxcare.com) and Gilead Sciences today announced the launch of TRxETM, an innovative treatment and adherence support service customized for patients with HIV.

In the treatment of patients with HIV infection, adherence to medication (known as highly active antiretroviral therapy - HAART) is vital to control viral replication and improve immune function. As such, it is essential to achieve more than 95 percent adherence to HAART to suppress viral replication and avoid the emergence of resistance. However, achieving such high rates of adherence is very challenging to patients. As a result medication non-adherence is a growing concern to clinicians, healthcare systems, and other stakeholders because of mounting evidence that it is associated with adverse outcomes and higher costs of care. The reasons for poor medication adherence are often multifactorial and can be managed by offering differing interventions.

One such intervention the new TRxETM service enables patients to maintain and better manage their treatment via a cloud-enabled smart phone application. By providing medication prompts and personalized interventions along with directions, which may include specific dietary requirements, TRxETM offers patients comprehensive treatment support. This is to ensure that patients remember to take their HIV treatment – the right way, the right time and to get the best results out of their prescribed treatment.

“TRxE is the product of many years of research experience. It enables patients and healthcare professionals to collaborate and to work as a team to continuously optimize treatment delivery, track outcomes, schedule clinic appointments and communicate utilizing secure instant messaging,” says TRxCARE CEO Markus Glimm.“ He adds,“It allows patients to become active participants in their own care and provides access to a library of resources of reliable and up-to-date content that enhances the patient’s ability to better understand relevant medical information.”
TRxETM connects to cloud services and runs on iPhones and Android phones, as well as on iPad and tablets running the Android operating system. A version for Blackberry and Nokia phones is in the works and will be released soon. The software/service is offered to patients taking one of Gilead Sciences HIV treatments by their clinics.

About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

About TRxCARE
TRxCARE (trxcare.com) is a global provider of disease-specific, individualized treatment delivery services designed to improve treatment adherence by engaging patients with physicians between visits utilising self-care smart phone apps and web portals securely connected to cloud services.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: TRxCARE

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


/RC/ TRxCARE Introduces New Innovative Treatment and Adherence Support Service

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Markus - TRxCARE.com 
+44(0)79 0098 3359 markus.glimm[.]trxcare.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any TRxCARE securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From TRxCARE / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  JobsWare.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)